<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>684</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>14734527</PubmedId>
            <Abstract>The products of the human leukocyte antigen subtypes HLA-B*2705 and HLA-B*2709 differ only in residue 116 (Asp vs. His) within the peptide binding groove but are differentially associated with the autoimmune disease ankylosing spondylitis (AS); HLA-B*2705 occurs in AS-patients, whereas HLA-B*2709 does not. The subtypes also generate differential T cell repertoires as exemplified by distinct T cell responses against the self-peptide pVIPR (RRKWRRWHL). The crystal structures described here show that pVIPR binds in an unprecedented dual conformation only to HLA-B*2705 molecules. In one binding mode, peptide pArg5 forms a salt bridge to Asp116, connected with drastically different interactions between peptide and heavy chain, contrasting with the second, conventional conformation, which is exclusively found in the case of B*2709. These subtype-dependent differences in pVIPR binding link the emergence of dissimilar T cell repertoires in individuals with HLA-B*2705 or HLA-B*2709 to the buried Asp116/His116 polymorphism and provide novel insights into peptide presentation by major histocompatibility antigens.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>271-81</ArticlePages>
            <ArticleTitle>Dual, HLA-B27 subtype-dependent conformation of a self-peptide.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Hülsmeyer</LastName>
                    <ForeName>Martin</ForeName>
                </Author>
                <Author>
                    <LastName>Fiorillo</LastName>
                    <ForeName>Maria Teresa</ForeName>
                </Author>
                <Author>
                    <LastName>Bettosini</LastName>
                    <ForeName>Francesca</ForeName>
                </Author>
                <Author>
                    <LastName>Sorrentino</LastName>
                    <ForeName>Rosa</ForeName>
                </Author>
                <Author>
                    <LastName>Saenger</LastName>
                    <ForeName>Wolfram</ForeName>
                </Author>
                <Author>
                    <LastName>Ziegler</LastName>
                    <ForeName>Andreas</ForeName>
                </Author>
                <Author>
                    <LastName>Uchanska-Ziegler</LastName>
                    <ForeName>Barbara</ForeName>
                </Author>
            </Authors>
            <Affiliations>Institut für Kristallographie, Freie Universität Berlin, 14195 Berlin, Germany.</Affiliations>
            <ArticleChemicalList>HLA-B Antigens;HLA-B*27:05 antigen;HLA-B*27:09 antigen;HLA-B27 Antigen</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Binding Sites(genetics); Cell Line; HLA-B Antigens(chemistry; genetics; metabolism); HLA-B27 Antigen(chemistry; classification; genetics; metabolism); Humans; Models, Molecular; Protein Binding; Protein Conformation; Spondylitis, Ankylosing(genetics; immunology); Static Electricity; T-Lymphocytes, Cytotoxic(immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>199</Volume>
                <Issue>2</Issue>
                <Title>The Journal of experimental medicine</Title>
                <Issn>0022-1007</Issn>
                <MedlineTa>J Exp Med</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>self-peptide pVIPR</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RRKWRRWHL</LinearSequence>
                        <StartingPosition>400</StartingPosition>
                        <EndingPosition>408</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P32241.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>55635</EpitopeId>
                <ReferenceStartingPosition>400</ReferenceStartingPosition>
                <ReferenceEndingPosition>408</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <MhcBindingId>6702</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>175</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.2</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>193</MhcAlleleId>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1OF2</ComplexPdbId>
                            <MhcChain1PdbChain>A</MhcChain1PdbChain>
                            <MhcChain2PdbChain>B</MhcChain2PdbChain>
                            <EpitopePdbChain>C</EpitopePdbChain>
                            <EpitopeResidues>C: R1, R2, K3, W4, R5, R6, W7, H8, L9</EpitopeResidues>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>B*2705 accommodates pVIPR [PDB: 1OGT] in non-canonical p6alpha conformation which is different  to that seen when pVIPR is complexed with B*2709 (this structure) (canonical p4alpha conformation). Only contacts that are different in these two structures are considered in the paper.</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>C: R1, R2, K3, W4, R5, R6, W7, H8, L9</EpitopeResidues>
                                <EpitopeResiduesInteractingWithMhc>C: R1, R2, K3, W4, R5, R6, W7, H8, L9</EpitopeResiduesInteractingWithMhc>
                                <MhcResiduesInteractingWithEpitope>A: R62, I66, L81, Y84, L95, Y99,  Y123, T143, K146, W147, V152, Q155,  W167</MhcResiduesInteractingWithEpitope>
                                <InteractingAtomPairs>&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;dataroot xmlns:od="urn:schemas-microsoft-com:officedata" generated="2005-06-13T18:50:03"&gt;
&lt;contacts_xxxx&gt;
&lt;AtomPairID&gt;1&lt;/AtomPairID&gt;
&lt;BindingID&gt;99&lt;/BindingID&gt;
&lt;PDB_ID&gt;1of2&lt;/PDB_ID&gt;
&lt;Antigen_Chain&gt;C&lt;/Antigen_Chain&gt;
&lt;Antigen_Residue&gt;K (Lys)&lt;/Antigen_Residue&gt;
&lt;Antigen_Residue_Position&gt;3&lt;/Antigen_Residue_Position&gt;
&lt;Antigen_Residue_Atom&gt;N&lt;/Antigen_Residue_Atom&gt;
&lt;Immunoglobulin_Chain&gt;A&lt;/Immunoglobulin_Chain&gt;
&lt;Immunoglobulin_Residue&gt;Y (Tyr)&lt;/Immunoglobulin_Residue&gt;
&lt;Immunoglobulin_Residue_Position&gt;99&lt;/Immunoglobulin_Residue_Position&gt;
&lt;Immunoglobulin_Residue_Atom&gt;OH&lt;/Immunoglobulin_Residue_Atom&gt;
&lt;Contact_Type&gt;Hydrogen bond&lt;/Contact_Type&gt;
&lt;/contacts_xxxx&gt;
&lt;contacts_xxxx&gt;
&lt;AtomPairID&gt;2&lt;/AtomPairID&gt;
&lt;BindingID&gt;99&lt;/BindingID&gt;
&lt;PDB_ID&gt;1of2&lt;/PDB_ID&gt;
&lt;Antigen_Chain&gt;C&lt;/Antigen_Chain&gt;
&lt;Antigen_Residue&gt;R (Arg)&lt;/Antigen_Residue&gt;
&lt;Antigen_Residue_Position&gt;5&lt;/Antigen_Residue_Position&gt;
&lt;Antigen_Residue_Atom&gt;NH1&lt;/Antigen_Residue_Atom&gt;
&lt;Immunoglobulin_Chain&gt;A&lt;/Immunoglobulin_Chain&gt;
&lt;Immunoglobulin_Residue&gt;Q (Gln)&lt;/Immunoglobulin_Residue&gt;
&lt;Immunoglobulin_Residue_Position&gt;155&lt;/Immunoglobulin_Residue_Position&gt;
&lt;Immunoglobulin_Residue_Atom&gt;OE1&lt;/Immunoglobulin_Residue_Atom&gt;
&lt;Contact_Type&gt;Hydrogen bond&lt;/Contact_Type&gt;
&lt;/contacts_xxxx&gt;
&lt;contacts_xxxx&gt;
&lt;AtomPairID&gt;3&lt;/AtomPairID&gt;
&lt;BindingID&gt;99&lt;/BindingID&gt;
&lt;PDB_ID&gt;1of2&lt;/PDB_ID&gt;
&lt;Antigen_Chain&gt;C&lt;/Antigen_Chain&gt;
&lt;Antigen_Residue&gt;R (Arg)&lt;/Antigen_Residue&gt;
&lt;Antigen_Residue_Position&gt;6&lt;/Antigen_Residue_Position&gt;
&lt;Antigen_Residue_Atom&gt;NH1&lt;/Antigen_Residue_Atom&gt;
&lt;Immunoglobulin_Chain&gt;A&lt;/Immunoglobulin_Chain&gt;
&lt;Immunoglobulin_Residue&gt;I (Ile)&lt;/Immunoglobulin_Residue&gt;
&lt;Immunoglobulin_Residue_Position&gt;66&lt;/Immunoglobulin_Residue_Position&gt;
&lt;Immunoglobulin_Residue_Atom&gt;O&lt;/Immunoglobulin_Residue_Atom&gt;
&lt;Contact_Type&gt;Hydrogen bond&lt;/Contact_Type&gt;
&lt;/contacts_xxxx&gt;
&lt;/dataroot&gt;</InteractingAtomPairs>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResiduesInteractingWithMhc>C: R1, R2, K3, W4, R5, R6, W7, H8, L9</EpitopeResiduesInteractingWithMhc>
                                <MhcResiduesInteractingWithEpitope>A: Y7, H9, T24, E45, Y59, R62, E63, Q65, I66, C67, A69, K70, T73, E76, D77, L81, Y84, Y99, H114, Y123, T143, K146, W147, V152, Q155, L156, Y159, E163, W167, Y171</MhcResiduesInteractingWithEpitope>
                                <ContactAreaForEpitope>1296.2</ContactAreaForEpitope>
                                <ContactAreaForMhc>879.2</ContactAreaForMhc>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <MhcBindingId>6701</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>175</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>1.47</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                        </AssayInformation>
                        <MhcAlleleId>190</MhcAlleleId>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1OGT</ComplexPdbId>
                            <MhcChain1PdbChain>A</MhcChain1PdbChain>
                            <MhcChain2PdbChain>B</MhcChain2PdbChain>
                            <EpitopePdbChain>C</EpitopePdbChain>
                            <EpitopeResidues>C: R1, R2, K3, W4, R5, R6, W7, H8, L9</EpitopeResidues>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>B*2705 accommodates pVIPR in non-canonical p6alpha conformation which is different  to that seen when pVIPR is complexed with B*2709 [PDB: 1OF2] (canonical p4alpha conformation). Only contacts that are different in these two structures are considered in the paper.</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>C: R1, R2, K3, W4, R5, R6, W7, H8, L9</EpitopeResidues>
                                <EpitopeResiduesInteractingWithMhc>C: R1, R2, K3, W4, R5, R6, W7, H8, L9</EpitopeResiduesInteractingWithMhc>
                                <MhcResiduesInteractingWithEpitope>A: R62, L81, Y84, L95, Y99, D116, Y123, T143, K146, W147, L156, W167</MhcResiduesInteractingWithEpitope>
                                <InteractingAtomPairs>&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;dataroot xmlns:od="urn:schemas-microsoft-com:officedata" generated="2005-06-13T18:49:07"&gt;
&lt;contacts_xxxx&gt;
&lt;AtomPairID&gt;1&lt;/AtomPairID&gt;
&lt;BindingID&gt;98&lt;/BindingID&gt;
&lt;PDB_ID&gt;1ogt&lt;/PDB_ID&gt;
&lt;Antigen_Chain&gt;C&lt;/Antigen_Chain&gt;
&lt;Antigen_Residue&gt;K (Lys)&lt;/Antigen_Residue&gt;
&lt;Antigen_Residue_Position&gt;3&lt;/Antigen_Residue_Position&gt;
&lt;Antigen_Residue_Atom&gt;N&lt;/Antigen_Residue_Atom&gt;
&lt;Immunoglobulin_Chain&gt;A&lt;/Immunoglobulin_Chain&gt;
&lt;Immunoglobulin_Residue&gt;Y (Tyr)&lt;/Immunoglobulin_Residue&gt;
&lt;Immunoglobulin_Residue_Position&gt;99&lt;/Immunoglobulin_Residue_Position&gt;
&lt;Immunoglobulin_Residue_Atom&gt;OH&lt;/Immunoglobulin_Residue_Atom&gt;
&lt;Contact_Type&gt;Hydrogen bond&lt;/Contact_Type&gt;
&lt;/contacts_xxxx&gt;
&lt;contacts_xxxx&gt;
&lt;AtomPairID&gt;2&lt;/AtomPairID&gt;
&lt;BindingID&gt;98&lt;/BindingID&gt;
&lt;PDB_ID&gt;1ogt&lt;/PDB_ID&gt;
&lt;Antigen_Chain&gt;C&lt;/Antigen_Chain&gt;
&lt;Antigen_Residue&gt;K (Lys)&lt;/Antigen_Residue&gt;
&lt;Antigen_Residue_Position&gt;3&lt;/Antigen_Residue_Position&gt;
&lt;Antigen_Residue_Atom&gt;O&lt;/Antigen_Residue_Atom&gt;
&lt;Immunoglobulin_Chain&gt;A&lt;/Immunoglobulin_Chain&gt;
&lt;Immunoglobulin_Residue&gt;Y (Tyr)&lt;/Immunoglobulin_Residue&gt;
&lt;Immunoglobulin_Residue_Position&gt;99&lt;/Immunoglobulin_Residue_Position&gt;
&lt;Immunoglobulin_Residue_Atom&gt;OH&lt;/Immunoglobulin_Residue_Atom&gt;
&lt;Contact_Type&gt;Hydrogen bond&lt;/Contact_Type&gt;
&lt;/contacts_xxxx&gt;
&lt;contacts_xxxx&gt;
&lt;AtomPairID&gt;3&lt;/AtomPairID&gt;
&lt;BindingID&gt;98&lt;/BindingID&gt;
&lt;PDB_ID&gt;1ogt&lt;/PDB_ID&gt;
&lt;Antigen_Chain&gt;C&lt;/Antigen_Chain&gt;
&lt;Antigen_Residue&gt;R (Arg)&lt;/Antigen_Residue&gt;
&lt;Antigen_Residue_Position&gt;5&lt;/Antigen_Residue_Position&gt;
&lt;Antigen_Residue_Atom&gt;NH1&lt;/Antigen_Residue_Atom&gt;
&lt;Immunoglobulin_Chain&gt;A&lt;/Immunoglobulin_Chain&gt;
&lt;Immunoglobulin_Residue&gt;D (Asp)&lt;/Immunoglobulin_Residue&gt;
&lt;Immunoglobulin_Residue_Position&gt;116&lt;/Immunoglobulin_Residue_Position&gt;
&lt;Immunoglobulin_Residue_Atom&gt;OD1&lt;/Immunoglobulin_Residue_Atom&gt;
&lt;Contact_Type&gt;Salt bridge&lt;/Contact_Type&gt;
&lt;/contacts_xxxx&gt;
&lt;contacts_xxxx&gt;
&lt;AtomPairID&gt;4&lt;/AtomPairID&gt;
&lt;BindingID&gt;98&lt;/BindingID&gt;
&lt;PDB_ID&gt;1ogt&lt;/PDB_ID&gt;
&lt;Antigen_Chain&gt;C&lt;/Antigen_Chain&gt;
&lt;Antigen_Residue&gt;R (Arg)&lt;/Antigen_Residue&gt;
&lt;Antigen_Residue_Position&gt;5&lt;/Antigen_Residue_Position&gt;
&lt;Antigen_Residue_Atom&gt;NH2&lt;/Antigen_Residue_Atom&gt;
&lt;Immunoglobulin_Chain&gt;A&lt;/Immunoglobulin_Chain&gt;
&lt;Immunoglobulin_Residue&gt;D (Asp)&lt;/Immunoglobulin_Residue&gt;
&lt;Immunoglobulin_Residue_Position&gt;116&lt;/Immunoglobulin_Residue_Position&gt;
&lt;Immunoglobulin_Residue_Atom&gt;OD2&lt;/Immunoglobulin_Residue_Atom&gt;
&lt;Contact_Type&gt;Salt bridge&lt;/Contact_Type&gt;
&lt;/contacts_xxxx&gt;
&lt;/dataroot&gt;</InteractingAtomPairs>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResiduesInteractingWithMhc>C: R1, R2, K3, W4, R5, R6, W7, H8, L9</EpitopeResiduesInteractingWithMhc>
                                <MhcResiduesInteractingWithEpitope>A: Y7, H9, T24, E45, Y59, R62, E63, I66, C67, A69, K70, T73, E76, D77, T80, L81, Y84, L95, Y99, H114, T143, K146, W147, V152, Q155, L156, Y159, E163, W167, Y171</MhcResiduesInteractingWithEpitope>
                                <ContactAreaForEpitope>1286.8</ContactAreaForEpitope>
                                <ContactAreaForMhc>864.0</ContactAreaForMhc>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

